Anhui Provincial Cancer Hospital

This study is testing whether adding a new two-in-one immunotherapy drug (QL1706) to standard chemotherapy works better than chemotherapy alone for people with advanced non-small cell lung cancer. It is for patients whose cancer has started growing again after their first treatme…

This study is testing a new combination treatment for people newly diagnosed with extensive-stage small cell lung cancer, a fast-growing and aggressive form of the disease. It combines an immunotherapy drug (tislelizumab) with standard chemotherapy and radiation therapy. The main…

This study is testing a new, noninvasive way to detect and evaluate heart valve diseases. Researchers want to see if a simple scan of a person's finger can accurately capture their pulse wave and reveal problems like aortic regurgitation or stenosis. The study will compare scans …